TY - JOUR
T1 - Chapter 22 Timing of neuronal replacement in cerebellar degenerative ataxia of Purkinje cell type
AU - Ghetti, B.
AU - Triarhou, L. C.
AU - Alyea, C. J.
AU - Low, W. C.
AU - Chang, A. C.
PY - 1990/1/1
Y1 - 1990/1/1
N2 - The “Purkinje cell degeneration” (pcd) mutant is characterized by a genetically determined loss of virtually all Purkinje cells between 17 and 45 days of age. The mutation is recessive; homozygous females (pcd/pcd) are fertile, whereas homozygous males are sterile. In solid cerebellar grafts, transplanted in pcd mutants, donor Purkinje cells survive and differentiate. The extent, pattern, and timing of degeneration, along with a comparative analysis of data from other cerebellar mutants characterized by Purkinje cell deficits, support the notion that all of these changes are most likely secondary to the loss of Purkinje cells. Thus, it appears that in pcd mutants as well, transneuronal losses proceed at a slower rate than losses that are under a primary genetic influence. To prevent transneuronal cell loss, the transplantation of Purkinje cells should optimally be carried out before such losses have occurred. However, the fate of donor Purkinje cells, grafted at the onset of host Purkinje cell degeneration, remains undefined.
AB - The “Purkinje cell degeneration” (pcd) mutant is characterized by a genetically determined loss of virtually all Purkinje cells between 17 and 45 days of age. The mutation is recessive; homozygous females (pcd/pcd) are fertile, whereas homozygous males are sterile. In solid cerebellar grafts, transplanted in pcd mutants, donor Purkinje cells survive and differentiate. The extent, pattern, and timing of degeneration, along with a comparative analysis of data from other cerebellar mutants characterized by Purkinje cell deficits, support the notion that all of these changes are most likely secondary to the loss of Purkinje cells. Thus, it appears that in pcd mutants as well, transneuronal losses proceed at a slower rate than losses that are under a primary genetic influence. To prevent transneuronal cell loss, the transplantation of Purkinje cells should optimally be carried out before such losses have occurred. However, the fate of donor Purkinje cells, grafted at the onset of host Purkinje cell degeneration, remains undefined.
UR - http://www.scopus.com/inward/record.url?scp=0024991687&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024991687&partnerID=8YFLogxK
U2 - 10.1016/S0079-6123(08)62605-9
DO - 10.1016/S0079-6123(08)62605-9
M3 - Article
C2 - 2290936
AN - SCOPUS:0024991687
SN - 0079-6123
VL - 82
SP - 197
EP - 202
JO - Progress in Brain Research
JF - Progress in Brain Research
IS - C
ER -